Expected Impact:

The cooperation on lung cancer is expected to generate new data and findings on lung cancer screening and mortality, and to provide guidance to Member States that are rolling out or planning to implement lung cancer screening programmes.

Objective:

Under the EU-USA collaboration on cancer, two technical working groups have been established, one focusing on paediatric cancer and the other on lung cancer. Each technical working group is progressing in defining a demonstration project, aiming at enhancing the EUUSA cooperation in paediatric and lung cancer domains. The EU-USA cooperation on lung cancer aims to start a joint cohort modelling, to assess geographical distribution of tobacco prevalence and lung cancer burden, and to assess potential effects of lung cancer screening on mortality, based on different eligibility criteria for screening. Through the collection of data with a harmonised methodology, the joint demonstration project on lung cancer will contribute to foster a uniform use and interpretation of data across EU and US involved participants on lung cancer screening. Considering the need for more and better data to identify and target higher risk lung cancer profiles, such as heavy smokers/ex-smokers, the aggregated results of the investigation have the objective to contribute in advancing the use and re-use of health data for research and innovation in lung cancer primary and secondary prevention policies.

Scope:

This action will support the Europe’s Beating Cancer Plan by seeking synergies between the USA Cancer Moonshot Initiative, and Europe’s Beating Cancer Plan and the EU Cancer Mission